Pradaxa Internal Bleeding Lawsuits Rise 50% since September 2012
By Andrea Gressman
Boehringer Ingelheim, the German drug manufacturer of Pradaxa, has come under a fire of Pradaxa lawsuits this past year. Shockingly, in a November 14, 2012 statement released by the Judicial Panel on Multidistrict Litigation, since September 5, 2012 the number of Pradaxa internal bleeding lawsuits have increased by 50%. This has created a drastic situation for Boehringer Ingelheim, which would explain their announcement in November that they are now working on an antidote to combat the internal bleeding side effects associated with Pradaxa.
Hundreds of Deaths Have Been Reported Due to Pradaxa Bleeding
On August 19, 2011 USA Today published an article stating that Pradaxa was the leader when it came to side effect reports of medications in 2011 to the FDA Ð something Boehringer Ingelheim is probably not too proud of. The report when on to state that at that time there had been 3,781 side effects reported to the FDA and 542 deaths. However, with the Judicial Panel on Multidistrict Litigation’s report on the number of Pradaxa bleeding lawsuits increasing at such a rapid rate it is easy to guess that these numbers are most likely a lot higher now just three months later.
The Institute for Safe Medicine Practices QuarterWatch that was released on October 3, 2012 said it was estimated that the complaints of negative drug side effects that have been issued to the FDA have risen a whopping 90% just in the last 4 years. The two drugs given the credit for 37% of the increase are Chantix and Pradaxa.
The main issue for Pradaxa users and its potentially fatal internal bleeding side effects is the fact that there is no antidote once the internal bleeding begins. Other drugs similar to Pradaxa have also been linked to internal bleeding but they also have an effective antidote treatment in the situations where internal bleeding does occur. That is not the case with Pradaxa and as a result fatalities continue to occur.
Pradaxa Lawsuit MDL Established to Handle Quantity of Cases Being Filed
Because of the flood of Pradaxa lawsuits, there was a Pradaxa MDL established, which is currently located in Illinois. It is referred to as MDL No. 2385, IN RE: Pradaxa Liability Litigation, Southern District of Illinois. The Pradaxa lawsuit MDL was established to handle the number of Pradaxa lawsuits in a more efficient manner and is currently being heard by the U.S. District Judge David Herndon.
If you or someone you know has been negatively affected by Pradaxa and it internal bleeding side effect, it is important that you speak with a Pradaxa lawsuit attorney as soon as possible regarding your legal options. It is important that you select a Pradaxa lawyer that knows the current status of the Pradaxa lawsuit litigation process as these types of cases can be specialized in nature.
Visit the Pradaxa Internal Bleeding Class Action Lawsuit Investigation today to learn more about your legal options when it comes to filing a Pradaxa lawsuit. Provide your information and you will receive a free consultation from a qualified Pradaxa lawsuit lawyer.
Updated December 18th, 2012
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
